High-Tech Gruenderfonds (HTGF), a German state and corporate-backed early-stage investment firm, has backed two more Germany-based companies.
HTGF invested an undisclosed amount of seed money in delivery service Lockbox and backed a €6.3m ($9m) series C round raised by Humedics, the developer of a breath test for liver damage.
Venture capital firms Vesalius Biocapital Partners and Seventure Partners, which in December launched its €120m Health for Life Capital Fund with corporates Danone, Tereos, Tornier and Lesaffre as strategic limited partners, were new investors in Humedics’ C round,while all investors from previous rounds also participated.
The previous syndicate included Peppermint VenturePartners (PVP, managing the Charité Biomedical Fund – CBF); the €52m VC Fonds Technologie managed by IBB-Beteiligungsgesellschaft and subsidised by the state’s Investitionsbank Berlin (IBB) and the European Regional Development Fund (ERDF); federal Germany-backed development bank KFW’s ERP Startfonds; listed venture firm Ventegis Capital; and HTGF.
Of note, the CBF fund’s first of seven investments was to lead Humedics’ 2011 series A round, which raised an undisclosed sum, after Humedics spun-out from Charité – Universitätsmedizin Berlin, a university clinic in Germany’s capital.
Humedics will use the money to commercialise its Limax breath test and the corresponding Flip diagnostic device.
Lockbox will use the seed financing to support growth as it prepares to expand its secure delivery service from Berlin to other German cities.
– A version of this article originally appeared on Global Government Venturing. Photo courtesy of Humedics GmbH.